Heterozygous Mutations in Aromatic Amino Acid Synthesis Genes Trigger TOR Pathway Activation in Saccharomyces

Makailyn G Schoonover1, Eon C Chilson1, Erin D Strome1

  • 1Northern Kentucky University.

Micropublication Biology
|December 5, 2022
PubMed

Insights

Mutations in aromatic amino acid biosynthesis alter nutrient pools, impacting the Target of Rapamycin (TOR) pathway. This study reveals how these changes affect TOR signaling and cellular processes like growth and autophagy.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The Target of Rapamycin (TOR) pathway, comprising TORC1 and TORC2, regulates crucial cellular functions such as growth and autophagy in response to nutrient cues.
  • While external nutrient regulation of TOR is well-studied, the effects of altered internal nutrient pools due to mutations in metabolic pathways remain largely unknown.

Purpose of the Study:

  • To investigate the impact of heterozygous mutations in aromatic amino acid biosynthesis genes on TOR pathway activity.
  • To analyze the downstream gene expression of TORC1 and assess autophagy induction as indicators of TORC1 and TORC2 signaling.

Main Methods:

  • Analysis of gene expression downstream of TORC1 in yeast strains with heterozygous mutations in aromatic amino acid biosynthesis genes.
  • Monitoring of autophagy induction as a readout for TORC1 and TORC2 activity.

Main Results:

  • Heterozygous mutations in aromatic amino acid biosynthesis genes lead to significant alterations in TOR signaling.
  • Differential gene expression patterns downstream of TORC1 were observed, indicating pathway modulation.
  • Changes in autophagy induction suggest a functional impact on both TORC1 and TORC2.

Conclusions:

  • Internal nutrient pool alterations, caused by mutations in metabolic pathways, can significantly impact TOR signaling.
  • This study highlights a novel mechanism connecting amino acid biosynthesis to TOR pathway regulation.
  • Findings provide insights into cellular adaptation to metabolic stress and its effect on fundamental processes like growth and autophagy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K